COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02149160
Recruitment Status : Unknown
Verified May 2015 by FORUM Pharmaceuticals Inc.
Recruitment status was:  Active, not recruiting
First Posted : May 29, 2014
Last Update Posted : March 23, 2016
Information provided by (Responsible Party):
FORUM Pharmaceuticals Inc

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 2016
Study Completion Date : No date given